EDIT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.90%

Insider Buying (Last 12 Months): $253,800.00

Insider Selling (Last 12 Months): $1,101,562.89

Editas Medicine Insider Trading History Chart

Editas Medicine Share Price & Price History

^$2.41

▼ -0.07 (-2.82%)

As of 11/20/2024 01:00 AM ET

Days: 30 | 90 | 365

Trump won. Buy this coin now.

From Weiss Ratings | Ad

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

This could be his favorite coin.

Editas Medicine Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/4/2024	Baisong Mei	EVP	Sell	518	$3.42	$1,771.56	133,895
9/4/2024	Gilmore Neil O'neill	CEO	Sell	1,555	$3.42	$5,318.10	313,724
7/25/2024	Linda Burkly	EVP	Sell	11,886	$5.42	$64,422.12	73,136
7/19/2024	Baisong Mei	EVP	Sell	6,619	$5.21	$34,484.99	134,413
6/4/2024	Baisong Mei	EVP	Sell	511	$5.50	$2,810.50	141,032
6/4/2024	Gilmore Neil O'neill	CEO	Sell	12,191	$5.50	$67,050.50	315,279
5/13/2024	Jessica Hopfield	Director	Buy	45,000	$5.64	$253,800.00	67,700
3/5/2024	Gilmore Neil O'neill	CEO	Sell	77,824	$9.42	$733,102.08	327,470
3/4/2024	Baisong Mei	SVP	Sell	20,327	$9.42	$191,480.34	141,543
12/5/2023	Bruce Eaton	EVP	Sell	103	$10.90	$1,122.70	74,791
11/7/2023	Bruce Eaton	EVP	Sell	139	$8.40	$1,167.60	75,589
9/6/2023	Bruce Eaton	EVP	Sell	103	$8.82	$908.46	75,728
8/11/2023	Bruce Eaton	EVP	Sell	702	$8.59	$6,030.18	75,831
8/8/2023	Bruce Eaton	EVP	Sell	141	$8.39	$1,182.99	76,533
7/19/2023	Baisong Mei	SVP	Sell	4,317	$8.80	$37,989.60	72,055
6/5/2023	Bruce Eaton	EVP	Sell	105	$9.50	$997.50	76,674
6/5/2023	Gilmore Neil O'neill	CEO	Sell	6,486	$9.50	$61,617.00	130,169
5/11/2023	Bruce Eaton	EVP	Sell	668	$9.87	$6,593.16	76,779
5/11/2023	Michelle Robertson	CFO	Sell	949	$9.87	$9,366.63	106,610
5/9/2023	Bruce Eaton	EVP	Sell	135	$9.51	$1,283.85	77,447
3/3/2023	Bruce Eaton	EVP	Sell	101	$8.89	$897.89	77,582
3/3/2023	Michelle Robertson	CFO	Sell	184	$8.89	$1,635.76	107,559
2/13/2023	Mark S Shearman	EVP	Sell	2,790	$9.67	$26,979.30	65,559
2/13/2023	Michelle Robertson	CFO	Sell	4,287	$9.67	$41,455.29	76,243
2/7/2023	Bruce Eaton	EVP	Sell	346	$11.10	$3,840.60	64,290
1/10/2023	Michelle Robertson	CFO	Sell	1,752	$8.16	$14,296.32	80,530
11/8/2022	Bruce Eaton	EVP	Sell	289	$11.02	$3,184.78	64,738
6/15/2022	Mark S Shearman	EVP	Sell	5,145	$10.06	$51,758.70	68,349
6/3/2022	Bruce Eaton	EVP	Sell	1,123	$11.54	$12,959.42	65,421
6/3/2022	Michelle Robertson	CFO	Sell	1,527	$11.54	$17,621.58	82,667
5/9/2022	Bruce Eaton	EVP	Sell	297	$13.11	$3,893.67	66,544
4/1/2022	Bruce Eaton	EVP	Sell	1,258	$19.64	$24,707.12	66,841
3/3/2022	Bruce Eaton	EVP	Sell	403	$17.33	$6,983.99
3/3/2022	Michelle Robertson	CFO	Sell	767	$17.33	$13,292.11
2/8/2022	Bruce Eaton	EVP	Sell	302	$17.63	$5,324.26
1/11/2022	Michelle Robertson	CFO	Sell	1,744	$25.70	$44,820.80

JD Vance Predicts: Wall Street vs. Trump & Your Money

From Priority Gold | Ad

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.

SEC Filings (Institutional Ownership Changes) for Editas Medicine (NASDAQ:EDIT)

71.90% of Editas Medicine stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Editas Medicine Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	178,507	$0.61M	0.0%	+46.9%	0.216%
11/16/2024	Geode Capital Management LLC	1,887,696	$6.44M	0.0%	-4.0%	2.287%
11/15/2024	Barclays PLC	178,507	$0.61M	0.0%	+46.9%	0.216%
11/15/2024	Public Employees Retirement System of Ohio	33,203	$0.11M	0.0%	+172.1%	0.040%
11/15/2024	Y Intercept Hong Kong Ltd	13,662	$47K	0.0%	N/A	0.017%
11/15/2024	XTX Topco Ltd	52,558	$0.18M	0.0%	N/A	0.064%
11/15/2024	State Street Corp	2,462,022	$8.40M	0.0%	-46.4%	2.982%
11/15/2024	Stifel Financial Corp	624,876	$2.13M	0.0%	+37.9%	0.757%
11/15/2024	Point72 DIFC Ltd	54,775	$0.19M	0.0%	N/A	0.066%
11/15/2024	Point72 Asset Management L.P.	107,360	$0.37M	0.0%	N/A	0.130%
11/15/2024	Jacobs Levy Equity Management Inc.	529,834	$1.81M	0.0%	+133.2%	0.642%
11/15/2024	Paloma Partners Management Co	19,416	$66K	0.0%	N/A	0.024%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	93,789	$0.32M	0.1%	N/A	0.114%
11/15/2024	Erste Asset Management GmbH	15,000	$52K	0.0%	N/A	0.018%
11/14/2024	PDT Partners LLC	39,546	$0.14M	0.0%	-84.0%	0.048%
11/14/2024	Verition Fund Management LLC	22,990	$78K	0.0%	N/A	0.028%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	897,533	$3.06M	0.0%	-0.5%	1.087%
11/14/2024	MetLife Investment Management LLC	29,518	$0.10M	0.0%	-37.5%	0.036%
11/13/2024	Townsquare Capital LLC	29,923	$0.10M	0.0%	+169.8%	0.036%
11/13/2024	BNP Paribas Financial Markets	54,787	$0.19M	0.0%	+37.3%	0.066%
11/13/2024	FMR LLC	203,087	$0.69M	0.0%	+110.7%	0.246%
11/13/2024	Dynamic Technology Lab Private Ltd	70,408	$0.24M	0.0%	N/A	0.085%
11/12/2024	Charles Schwab Investment Management Inc.	617,280	$2.11M	0.0%	-15.8%	0.748%
11/9/2024	Intech Investment Management LLC	28,606	$98K	0.0%	N/A	0.035%
11/8/2024	Jennison Associates LLC	237,745	$0.81M	0.0%	+90.4%	0.288%
11/7/2024	Drive Wealth Management LLC	18,937	$65K	0.0%	N/A	0.023%
11/5/2024	GSA Capital Partners LLP	182,725	$0.62M	0.0%	+89.0%	0.222%
11/4/2024	Los Angeles Capital Management LLC	117,639	$0.40M	0.0%	-10.2%	0.143%
10/29/2024	Arcadia Investment Management Corp MI	11,300	$39K	0.0%	N/A	0.014%
10/25/2024	China Universal Asset Management Co. Ltd.	15,863	$54K	0.0%	+64.2%	0.019%
10/23/2024	Ballentine Partners LLC	10,673	$36K	0.0%	N/A	0.013%
10/23/2024	Hennion & Walsh Asset Management Inc.	226,756	$0.77M	0.0%	+34.7%	0.276%
10/22/2024	International Assets Investment Management LLC	113,863	$0.39M	0.0%	+262.0%	0.138%
10/22/2024	Signaturefd LLC	9,326	$32K	0.0%	+494.8%	0.011%
10/19/2024	Allspring Global Investments Holdings LLC	24,485	$83K	0.0%	+20.0%	0.030%
10/11/2024	Creative Planning	21,563	$74K	0.0%	+113.7%	0.026%
10/7/2024	Green Alpha Advisors LLC	43,333	$0.15M	0.1%	+43.2%	0.053%
10/3/2024	SG Americas Securities LLC	40,096	$0.14M	0.0%	N/A	0.049%
8/15/2024	Susquehanna Portfolio Strategies LLC	110,972	$0.52M	0.0%	-39.3%	0.135%
8/15/2024	The Manufacturers Life Insurance Company	33,599	$0.16M	0.0%	+10.1%	0.041%
8/15/2024	Millennium Management LLC	2,459,629	$11.49M	0.0%	+10.0%	2.991%
8/15/2024	AQR Capital Management LLC	45,890	$0.21M	0.0%	+117.2%	0.056%
8/15/2024	Caxton Associates LP	128,510	$0.60M	0.0%	N/A	0.156%
8/14/2024	Squarepoint Ops LLC	694,180	$3.24M	0.0%	-22.7%	0.844%
8/14/2024	Marshall Wace LLP	449,153	$2.10M	0.0%	-43.2%	0.546%
8/14/2024	Integral Health Asset Management LLC	675,000	$3.15M	0.3%	+50.0%	0.821%
8/14/2024	ProShare Advisors LLC	16,095	$75K	0.0%	-21.5%	0.020%
8/14/2024	Profund Advisors LLC	39,808	$0.19M	0.0%	-67.9%	0.048%
8/12/2024	Hsbc Holdings PLC	104,794	$0.49M	0.0%	+148.1%	0.127%
8/12/2024	E Fund Management Co. Ltd.	13,051	$61K	0.0%	-65.7%	0.016%
8/9/2024	Renaissance Technologies LLC	98,429	$0.46M	0.0%	-89.0%	0.120%
8/9/2024	Dimensional Fund Advisors LP	2,345,054	$10.95M	0.0%	-10.1%	2.852%
8/8/2024	American Century Companies Inc.	126,240	$0.59M	0.0%	+13.6%	0.154%
8/6/2024	Koss Olinger Consulting LLC	10,000	$47K	0.0%	N/A	0.012%
8/6/2024	Los Angeles Capital Management LLC	130,949	$0.61M	0.0%	-11.5%	0.159%
8/5/2024	Victory Capital Management Inc.	10,572	$49K	0.0%	-86.5%	0.013%
8/1/2024	Rhumbline Advisers	137,986	$0.64M	0.0%	+2.9%	0.168%
7/30/2024	International Assets Investment Management LLC	31,457	$0.15M	0.0%	+10.5%	0.038%
7/29/2024	Principal Financial Group Inc.	11,163	$52K	0.0%	-44.3%	0.014%
7/26/2024	Allspring Global Investments Holdings LLC	20,396	$95K	0.0%	N/A	0.025%
7/26/2024	Bank of New York Mellon Corp	296,154	$1.38M	0.0%	+4.0%	0.360%
7/25/2024	Aries Wealth Management	13,850	$65K	0.0%	N/A	0.017%
7/20/2024	Hennion & Walsh Asset Management Inc.	168,371	$0.79M	0.0%	N/A	0.205%
7/19/2024	Raymond James & Associates	526,815	$2.46M	0.0%	+49.7%	0.641%
7/19/2024	Hoylecohen LLC	11,834	$55K	0.0%	N/A	0.014%
7/19/2024	Spectrum Planning & Advisory Services Inc.	12,051	$57K	0.1%	N/A	0.015%
7/18/2024	Assenagon Asset Management S.A.	23,330	$0.11M	0.0%	-59.1%	0.028%
5/20/2024	Virtu Financial LLC	40,461	$0.30M	0.0%	-45.2%	0.049%
5/16/2024	California State Teachers Retirement System	74,357	$0.55M	0.0%	-5.8%	0.090%
5/16/2024	Jacobs Levy Equity Management Inc.	119,140	$0.88M	0.0%	-58.2%	0.145%
5/16/2024	Kennedy Capital Management LLC	133,214	$0.99M	0.0%	N/A	0.162%
5/16/2024	Bayesian Capital Management LP	24,400	$0.18M	0.0%	N/A	0.030%
5/15/2024	Price T Rowe Associates Inc. MD	49,704	$0.37M	0.0%	+16.9%	0.060%
5/14/2024	EntryPoint Capital LLC	9,669	$72K	0.1%	N/A	0.012%
5/14/2024	Shell Asset Management Co.	87,967	$0.65M	0.0%	+33.5%	0.107%
5/10/2024	Vanguard Group Inc.	8,555,597	$63.48M	0.0%	+1.1%	10.404%
5/8/2024	Russell Investments Group Ltd.	12,838	$95K	0.0%	+147.4%	0.016%
5/8/2024	Headlands Technologies LLC	9,493	$70K	0.0%	+481.7%	0.012%
5/7/2024	Susquehanna Portfolio Strategies LLC	182,673	$1.36M	0.0%	-5.4%	0.222%
5/2/2024	Jennison Associates LLC	106,520	$0.79M	0.0%	+29.1%	0.130%
5/1/2024	BNP Paribas Financial Markets	82,810	$0.61M	0.0%	-61.5%	0.101%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	314,774	$2.25M	0.0%	+59.0%	0.383%
4/30/2024	HB Wealth Management LLC	10,198	$76K	0.0%	N/A	0.012%
4/29/2024	China Universal Asset Management Co. Ltd.	15,713	$0.12M	0.0%	+66.3%	0.019%
4/24/2024	Assenagon Asset Management S.A.	57,033	$0.42M	0.0%	+49.0%	0.069%
4/5/2024	Los Angeles Capital Management LLC	147,883	$1.10M	0.0%	N/A	0.181%
3/11/2024	Vanguard Group Inc.	8,461,857	$85.72M	0.0%	-0.9%	10.343%
2/26/2024	Virtu Financial LLC	73,886	$0.75M	0.1%	N/A	0.090%
2/16/2024	Public Employees Retirement System of Ohio	13,500	$0.14M	0.0%	N/A	0.017%
2/14/2024	Seven Eight Capital LP	146,345	$1.48M	0.2%	N/A	0.179%
2/13/2024	Tower Research Capital LLC TRC	6,432	$65K	0.0%	-69.2%	0.008%
2/13/2024	Rafferty Asset Management LLC	409,065	$4.14M	0.0%	-27.2%	0.501%
2/13/2024	Campbell & CO Investment Adviser LLC	51,301	$0.52M	0.0%	N/A	0.063%
2/9/2024	Aigen Investment Management LP	59,209	$0.60M	0.1%	N/A	0.072%
2/9/2024	Quest Partners LLC	47,681	$0.48M	0.1%	N/A	0.058%
2/9/2024	Trexquant Investment LP	241,754	$2.45M	0.1%	+28.9%	0.296%
2/8/2024	Mitsubishi UFJ Asset Management Co. Ltd.	22,672	$0.22M	0.0%	-22.9%	0.028%
2/7/2024	Dimensional Fund Advisors LP	2,392,396	$24.24M	0.0%	+40.6%	2.929%
2/7/2024	Jump Financial LLC	28,159	$0.29M	0.0%	+42.0%	0.034%
2/7/2024	BNP Paribas Financial Markets	215,011	$2.18M	0.0%	-60.8%	0.263%

Data available starting January 2016

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 BRILLIANCE trial for Leber Congenital Amaurosis; and reni-cel, a clinical development gene-edited medicine to treat sickle cell disease and transfusion-dependent beta-thalassemia. In addition, the company is developing alpha-beta T cells for solid and liquid tumors; and gamma delta T cell therapies to treat cancer. It has a research collaboration with Juno Therapeutics, Inc. to develop engineered T cells for cancer; strategic alliance and option agreement with Allergan Pharmaceuticals International Limited. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

Today's Range

Now: $2.41

$2.35

$2.48

50 Day Range

MA: $3.29

$2.48

$3.95

52 Week Range

Now: $2.41

$2.35

$11.69

Volume

2,814,305 shs

Average Volume

1,937,609 shs

Market Capitalization

$198.95 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.01

Who are the company insiders with the largest holdings of Editas Medicine?: Editas Medicine's top insider investors include:
Gilmore Neil O'neill (CEO)
Baisong Mei (SVP)
Baisong Mei (EVP)
Michelle Robertson (CFO)
Bruce Eaton (EVP)
Linda Burkly (EVP)
Jessica Hopfield (Director)
Mark S Shearman (EVP)
Learn More about top insider investors at Editas Medicine.
Who are the major institutional investors of Editas Medicine?: Editas Medicine's top institutional investors include:
State Street Corp — 2.98%
Geode Capital Management LLC — 2.29%
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 1.09%
Stifel Financial Corp — 0.76%
Charles Schwab Investment Management Inc. — 0.75%
Jacobs Levy Equity Management Inc. — 0.64%
Learn More about top institutional investors of Editas Medicine stock.
Which major investors are selling Editas Medicine stock?: During the previous quarter, EDIT stock was sold by these institutional investors:
State Street Corp
PDT Partners LLC
Charles Schwab Investment Management Inc.
Geode Capital Management LLC
MetLife Investment Management LLC
Los Angeles Capital Management LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Within the last year, company insiders that have sold Editas Medicine company stock include:
Gilmore Neil O'neill (CEO)
Baisong Mei (SVP)
Baisong Mei (EVP)
Michelle Robertson (CFO)
Bruce Eaton (EVP)
Learn More investors selling Editas Medicine stock.
Which major investors are buying Editas Medicine stock?: In the last quarter, EDIT stock was bought by institutional investors including:
Jacobs Levy Equity Management Inc.
Stifel Financial Corp
Jennison Associates LLC
Point72 Asset Management L.P.
FMR LLC
Point72 Asia Singapore Pte. Ltd.
GSA Capital Partners LLP
International Assets Investment Management LLC